The Opioid Industry Documents Archive (OIDA) is a collaborative undertaking between the University of California, San Francisco and Johns Hopkins University.
To collect, organize, preserve, and make freely accessible documents from opioid industry litigation to enable multiple audiences to explore and investigate information which shines a light on the opioid crisis.
The Opioid Industry Documents Archive is a state-of-the-art digital archive of industry litigation documents that will advance understanding of the root causes of the opioid epidemic and help address corporate behavior that is harmful to the public.
How to Search the OIDA
View or download the "How to Search the OIDA" quick start PDF guide
- Archive Shows How Fentanyl Promotion Helped Drive Opioid Epidemic via UCSF News, via Johns Hopkins University News
- 'Eat what you kill': How a fentanyl drugmaker bribed doctors, harmed patients and collected millions. (Ken Alltucker. USA Today, Dec 8, 2022).
New Industry Documents Highlight Role of Pharmacies in Driving Opioid Epidemic via UCSF News, via Johns Hopkins University News
- Documents detail how pharmacy giants Walgreens, CVS, and Walmart failed patients in the opioid crisis. By Lev Facher, Kate Sheridan, and Ed Silverman. STAT, Oct 14, 2022.
- New Documents Show McKinsey’s Role in Opioid Epidemic via UCSF News, via Johns Hopkins University News Releases
- Behind the Scenes, McKinsey Guided Companies at the Center of the Opioid Crisis. By Chris Hamby and Michael Forsythe. The New York Times, June 29, 2022.
- Opioid Industry Archive Releases 1.4 Million Documents from Leading Opioid Maker Implicated in Drug Crisis
via UCSF News, via Johns Hopkins University News Releases
- Inside the sales machine of the ‘kingpin’ of opioid makers. By Meryl Kornfield, Scott Higham and Steven Rich. The Washington Post, May 10, 2022.
How Does the OIDA Address the Opioid Crisis?
The opioid epidemic is the worst drug epidemic in our nation’s history, and nothing is more important to those who have been impacted than the truth – full transparency regarding how the epidemic occurred and how further harms can be abated. There are many other pressing questions as well, with answers that lie within documents from government litigation against pharmaceutical companies, including opioid manufacturers, distributors, and pharmacies, as well as litigation taking place in federal court on behalf of thousands of cities and counties in the United States.
These documents have been publicly released through state and federal investigations, settlement agreements, and other proceedings, including a lawsuit filed by The Washington Post and the Charleston Gazette
. The documents include emails, memos, presentations, sales reports, budgets, audit reports, Drug Enforcement Administration briefings, meeting agendas and minutes, expert witness reports, and depositions of drug company executives. The archive serves as a living repository of information that can be used to learn from the opioid epidemic so as to improve and safeguard public policy and public health, and to ensure that the opioid-related harms that have taken place never occur again.
Who Can Use the OIDA?
Our ultimate goal is to consolidate opioid litigation documents – and potentially additional information from sources such as the U.S. Food and Drug Administration, professional societies, and individuals and family members directly impacted by the epidemic – into a universally accessible and easy-to-use free digital archive for the benefit of individuals and communities, researchers, journalists, policymakers and other stakeholders affected by the opioid crisis. This resource provides immediate access to currently available documents and other information under the umbrella of the UCSF Industry Documents Library
Why UCSF and JHU?
The Opioid Industry Documents Archive leverages extraordinary expertise within the University of California, San Francisco and Johns Hopkins University. UCSF is home to the groundbreaking Truth Tobacco Industry Documents archive, which has fostered scientific and public health discoveries shaping tobacco policy in the U.S. and around the world. UCSF and JHU deliver excellence in library science, informational technology, and digital archiving, as well as scholarship focused on many dimensions of the opioid epidemic ranging from the history of medicine to pharmaceutical policy to clinical care, including through the UCSF Center for Tobacco Control Research and Education
, the Philip R. Lee Institute for Health Policy Studies
, the Department of Clinical Pharmacy
, the Department of Humanities and Social Sciences
, the Department of Family and Community Medicine
, and the UCSF Library
, as well as Johns Hopkins Bloomberg School of Public Health's Center for Drug Safety and Effectiveness
, the Johns Hopkins Welch Medical Library
, the Institute of the History of Medicine
, and the Sheridan Libraries' Digital Research and Curation Center
About the Documents
The documents are internal corporate records publicly disclosed from ongoing opioid litigation brought by local and state governments and tribal communities against opioid manufacturers, wholesalers, and pharmacies. These lawsuits argue that opioid manufacturers and distributors pursued manipulative and misleading marketing strategies, cast doubt on the addictiveness of the drug, and disregarded the significant risks to health, leading to a national opioid overdose epidemic and public health crisis. The documents reveal the many ways opioid litigation defendants sought to increase sales of drugs they knew to be addictive and deadly. Defendants’ tactics included using misleading marketing materials, enlisting health care providers as lobbyists, casting doubt on the drugs’ addictiveness, ignoring or downplaying health risks, and overlooking evidence of opioid oversupply and unsafe use.
The OIDA also includes plaintiff and defendant exhibits and depositions submitted during the course of opioid litigation in individual states as well as the federal multi-district litigation (MDL 2804).
Document types and topics include:
Email communications between sales representatives, physicians and other healthcare representatives; internal sales training materials, sales rep data, and compensation strategies; submissions to regulatory agencies regarding consumer guides, brochures, and prescribing information; graphics designs for product packaging and labeling; brochures and prescribing publications intended for physicians and the general public; advertisements and marketing materials; correspondence with physicians; and other internal documents.
Entities represented include:
Mallinckrodt; McKinsey & Company; Insys Therapeutics, Inc.; Johnson & Johnson; Janssen Pharmaceuticals; Qualitest; Purdue Pharma; Teva Pharmaceuticals; Drug Enforcement Administration (DEA); Richard Sackler; Paul Goldenheim; Actavis; McKesson; Cardinal Health; KeySource Medical; Walmart; Rite-Aid; CVS Pharmacy; Walgreens; Endo International; Healthcare Distribution Management Association (HDMA).
The public archive was created and funded in part through settlements of public interest lawsuits by states.
The Opioid Industry Documents Archive (OIDA) was created by UCSF and JHU as a public resource to aid in navigating these document collections. The OIDA is wholly committed to the principles of universal access to information and intellectual freedom and makes its collections freely available to all so that users can exercise their judgement and expertise in interpreting the documents in the broader context of available information and scientific inquiry. The description of any particular document on this website does not imply the OIDA's judgement of its content. While we have made every effort to provide accurate information about the archive's resources, this website may contain inadvertent descriptive or typographical errors. We reserve the right to make changes and corrections at any time, without notice.
Please contact us at email@example.com or firstname.lastname@example.org with any questions.